Table 2.
Descriptive analysis of the quantitative evaluation of bone marrow aspirates from 57 cats without alterations in complete blood counts.
| Lineage | Evaluated cells (%) | Mean | S.D.1 | Median | 25% | 75% | pRI∗ |
|---|---|---|---|---|---|---|---|
| Myeloid | 52.1 | 4.7 | 52.6 | 49 | 54.4 | ||
| Myeloblast | 1.6 | 0.8 | 1.6 | 1 | 2 | 0∼0.4 | |
| Promyelocyte | 3.6 | 1.7 | 3.4 | 2.6 | 4.4 | 0∼3 | |
| Neutrophilic myelocyte | 4.5 | 1.9 | 4.4 | 1 | 6 | 4.4∼13.2 | |
| Neutrophilic metamyelocyte | 3.9 | 1.4 | 3.8 | 3 | 5 | 0.6∼8.0 | |
| Rod neutrophil | 7.8 | 2.7 | 7.6 | 6 | 9.4 | 12.8∼16.6 | |
| Neutrophil | 26.3 | 4.1 | 25.8 | 24.2 | 28.4 | 6.8∼22.0 | |
| Eosinophilic myelocyte | 0.5 | 0.5 | 0.4 | 0.2 | 0.8 | 0.8∼3.2 (sum of eosinophilic series) | |
| Eosinophilic metamyelocyte | 0.6 | 0.6 | 0.4 | 0.2 | 0.8 | ||
| Rod eosinophil | 1 | 0.6 | 1 | 0.4 | 1.4 | ||
| Eosinophil | 2 | 1.2 | 1.8 | 1.8 | 2.6 | ||
| Basophilic series | 0.4 | 0.4 | 0.4 | 0 | 0.4 | 0∼0.4 | |
|
| |||||||
| Erythroid | 35.6 | 4 | 35 | 33.2 | 37.4 | ||
| Rubriblast | 1.1 | 0.5 | 1 | 3.2 | 5.9 | 0∼0.8 | |
| Prorubricyte | 4.9 | 2 | 4.6 | 3.4 | 6.4 | 0∼1.6 | |
| Rubricyte | 21.4 | 3.7 | 20.2 | 18.8 | 23.6 | 10.2∼29.4 | |
| Metarubricyte | 8.4 | 2.5 | 8.2 | 6.8 | 9.6 | 1.0∼10.4 | |
|
| |||||||
| Others | 12.2 | 3.7 | 12 | 10.8 | 15 | ||
| Lymphocyte | 9 | 3 | 8.8 | 7.6 | 11 | 11.6∼21.6 | |
| Plasma cell | 1.4 | 1.3 | 1 | 0.4 | 1.8 | 0.2∼1.6 | |
| Monocyte | 1.4 | 0.7 | 1.4 | 1 | 2 | 0∼0.2 | |
| Megakaryocytic series | 0.4 | 0.4 | 0.4 | 0.2 | 0.6 | Rare | |
|
| |||||||
| Myeloid/erythroid ratio | 1.49 | 0.25 | 1.34 | 1.54 | 1.65 | 1.21∼2.16 | |
1Standard deviation. ∗Reference interval (RI) previously published by Jain [5].